There's apparently been a lot of movement in the antimicrobial space about which the market is yet to be informed.
Additionally, an article where one of the Directors was quoted said there are many non-dilutive sources of funding for a phase II antimicrobial trial. Could be looking at a partnership or similar for that this quarter.
Then of course there is the AD phase II trial results. Not sure when they are scheduled but I think form memory that it is Q1 2020.
Looking Forward to a GREAT 2020, page-227
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.8¢ |
Change
0.003(0.77%) |
Mkt cap ! $592.7M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.5¢ | $1.109M | 3.382M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 897886 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 409401 | 11 |
View Market Depth
| Last trade - 15.09pm 11/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |